GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
50.35
+0.05 (+0.10%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close50.30
Open50.25
Bid50.45 x 1000
Ask52.00 x 3100
Day's Range50.18 - 50.79
52 Week Range38.01 - 57.83
Volume432,023
Avg. Volume600,911
Market Cap4.989B
Beta (3Y Monthly)1.01
PE Ratio (TTM)35.96
EPS (TTM)1.40
Earnings DateNov 6, 2019 - Nov 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.55
Trade prices are not sourced from all markets
  • IART or GMED: Which Is the Better Value Stock Right Now?
    Zacks

    IART or GMED: Which Is the Better Value Stock Right Now?

    IART vs. GMED: Which Stock Is the Better Value Option?

  • Does This Valuation Of Globus Medical, Inc. (NYSE:GMED) Imply Investors Are Overpaying?
    Simply Wall St.

    Does This Valuation Of Globus Medical, Inc. (NYSE:GMED) Imply Investors Are Overpaying?

    Today we will run through one way of estimating the intrinsic value of Globus Medical, Inc. (NYSE:GMED) by taking the...

  • Thomson Reuters StreetEvents

    Edited Transcript of GMED earnings conference call or presentation 1-Aug-19 8:30pm GMT

    Q2 2019 Globus Medical Inc Earnings Call

  • Globus Medical (GMED) Q2 Earnings In Line, Revenue View Up
    Zacks

    Globus Medical (GMED) Q2 Earnings In Line, Revenue View Up

    Globus Medical's (GMED) spine business gains traction from solid worldwide growth in the second quarter.

  • Globus Medical Inc (GMED) Q2 2019 Earnings Call Transcript
    Motley Fool

    Globus Medical Inc (GMED) Q2 2019 Earnings Call Transcript

    GMED earnings call for the period ending June 30, 2019.

  • GlobeNewswire

    Globus Medical Reports Second Quarter 2019 Results

    AUDUBON, Pa., Aug. 01, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended.

  • What You Must Know About Globus Medical, Inc.'s (NYSE:GMED) Financial Health
    Simply Wall St.

    What You Must Know About Globus Medical, Inc.'s (NYSE:GMED) Financial Health

    Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Globus Medical, Inc...

  • GlobeNewswire

    Globus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call

    AUDUBON, Pa., July 15, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended.

  • Does Globus Medical, Inc. (NYSE:GMED) Have A Particularly Volatile Share Price?
    Simply Wall St.

    Does Globus Medical, Inc. (NYSE:GMED) Have A Particularly Volatile Share Price?

    If you own shares in Globus Medical, Inc. (NYSE:GMED) then it's worth thinking about how it contributes to the...

  • GlobeNewswire

    Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the appointment of Keith W. Pfeil as its Senior Vice President and Chief Financial Officer effective August 19, 2019. Mr. Pfeil joins Globus Medical after almost 16 years at CSS Industries, a publicly traded consumer products company, in which he served in a number of financial leadership roles, most recently as Executive Vice President and Chief Financial Officer. Mr. Pfeil’s financial leadership experience includes experience with Financial Planning and Analysis, Internal Audit and Investor Relations.

  • Hedge Funds Have Never Been This Bullish On Globus Medical Inc (GMED)
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On Globus Medical Inc (GMED)

    The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 delivered very strong gains as a result, with the Russell 2000, which is composed of smaller companies, outperforming the large-cap stocks slightly during the first quarter. Unfortunately sentiment shifted […]

  • Markit

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Globus Medical Inc NYSE:GMEDView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for GMED with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GMED. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding GMED totaled $156 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Is Globus Medical, Inc.'s (NYSE:GMED) 12% ROE Better Than Average?
    Simply Wall St.

    Is Globus Medical, Inc.'s (NYSE:GMED) 12% ROE Better Than Average?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Globus Medical (GMED) Down 13.9% Since Last Earnings Report: Can It Rebound?
    Zacks

    Globus Medical (GMED) Down 13.9% Since Last Earnings Report: Can It Rebound?

    Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire

    Globus Medical Launches First Expandable Interspinous Fixation – AERIAL™

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of AERIAL™, a minimally invasive expandable interspinous fixation system with independent locking plates. This is Globus Medical’s first expandable interspinous fixation system, adding to their industry leading expandable technology portfolio. Dr. David Bomback, an orthopedic surgeon and partner at Connecticut Neck and Back Specialists, and Dr. Sumit Das, founder and neurosurgeon with Brain and Spine Neurosurgical Institute, recently performed the first AERIAL™ procedures at Danbury Hospital, Danbury, Connecticut, and Our Lady of Fatima Hospital, North Providence, Rhode Island, respectively.

  • Globus Medical Reveals Positive Study Results for ExcelsiusGPS
    Zacks

    Globus Medical Reveals Positive Study Results for ExcelsiusGPS

    Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure

  • GlobeNewswire

    New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®

    Globus Medical (GMED), a leading musculoskeletal solutions company today announced the results of a clinical study that evaluated the versatility of ExcelsiusGPS® Robotic navigation system compared to traditional pedicle screw placement techniques. Published in the Journal of Robotic Surgery, “Robotic-assisted navigated minimally invasive pedicle screw placement in the first 100 cases at a single institution,” demonstrated a 99% screw placement success rate with no malpositions or postoperative returns to the O.R. related to screw placement. The study explored how the ExcelsiusGPS® advanced navigated robotic technology combines the ability to use three imaging workflows (preoperative CT, intraoperative CT, and fluoroscopy) with navigation and guidance to accurately place pedicle screws with real-time feedback.

  • Q1 slump doesn't dim Globus CEO's expectations for robotic surgery system
    American City Business Journals

    Q1 slump doesn't dim Globus CEO's expectations for robotic surgery system

    Despite a first quarter sales slump, Globus Medical continues to be "bullish" about its robotic-assisted navigation and surgical system.  The Audubon medical products company launched the system, called ExcelsiusGPS, in late 2017. The ExcelsiusGPS system, which costs slightly more than $1 million, combines a rigid robotic arm and full navigation capabilities to provide surgeons with precise trajectory alignment in minimally invasive spine surgery.

  • Thomson Reuters StreetEvents

    Edited Transcript of GMED earnings conference call or presentation 2-May-19 8:30pm GMT

    Q1 2019 Globus Medical Inc Earnings Call

  • Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)
    Zacks

    Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)

    Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

  • Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak
    Zacks

    Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak

    Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

  • Globus Medical Inc (GMED) Q1 2019 Earnings Call Transcript
    Motley Fool

    Globus Medical Inc (GMED) Q1 2019 Earnings Call Transcript

    GMED earnings call for the period ending March 31, 2019.